NCT00144625View on ClinicalTrials.gov

Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA)

PHASE3CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

July 31, 2005

Study Completion Date

June 30, 2009

Conditions
Polyarticular Juvenile Idiopathic Arthritis
Interventions
DRUG

MRA(Tocilizumab)

8mg/kg/4weeks

Sponsors
All Listed Sponsors
lead

Chugai Pharmaceutical

INDUSTRY

NCT00144625 - Long-term Treatment Study of MRA for Polyarticular Juvenile Idiopathic Arthritis (pJIA) | Biotech Hunter | Biotech Hunter